University of Pennsylvania

Expert panel discussion to be held on managing BRCA-related cancer risk

Can two genes control your destiny? Recently there’s been an explosion of genetic testing with 75,000 genetic tests on the market and 10 new tests entering the market daily. The business of clinical genomics is forecast to grow to a $7.7 billion global industry by 2020. But the testing of two genes--BRCA1 and BRCA2, which when mutated are known to greatly increase the risk of breast and ovarian cancer, as well as other cancers such as prostate, melanoma and pancreatic--were identified 25 years ago. Like eye or hair color, there’s 50 percent chance of inheriting a mutation from either parent.

New science and technology are continually changing the landscape for mutation carriers...